Robert is Senior Director for Strategic Planning and Transversal Scientific Projects in Diabetes and Cardiovascular Global Medical Affairs at Sanofi. With more than 20 years of experience in academia and the pharmaceutical industry, he has led US and global medical affairs teams for a number of high profile cardiovascular and diabetes products at multiple companies, including Glucophage, Glucovance, Plavix, Eliquis, Onglyza, Epanova, and Crestor. He will serve as the industry co-lead for WP3.